A citation-based method for searching scientific literature








List of shared articles



Times cited

Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom.
Belinda S Lennerz, Andrew P Koutnik, Svetlana Azova, Joseph I Wolfsdorf, David S Ludwig. J Clin Invest 2021
2

Pharmacological therapies to address obesity in type 1 diabetes.
Anna Casu, Anika Bilal, Richard E Pratley. Curr Opin Endocrinol Diabetes Obes 2020
0

Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one-year retrospective matched cohort study.
Adham Mottalib, Shaheen Tomah, Samar Hafida, Taha Elseaidy, Megan Kasetty, Sahar Ashrafzadeh, Osama Hamdy. Diabetes Obes Metab 2019
7

Longitudinal Phenotypes of Type 1 Diabetes in Youth Based on Weight and Glycemia and Their Association With Complications.
Anna R Kahkoska, Crystal T Nguyen, Linda A Adair, Allison E Aiello, Kyle S Burger, John B Buse, Dana Dabelea, Lawrence M Dolan, Faisal S Malik, Amy K Mottl,[...]. J Clin Endocrinol Metab 2019
4

Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication Trial.
Anisoara Bumbu, Abdul Moutairou, Odette Matar, Frédéric Fumeron, Gilberto Velho, Jean-Pierre Riveline, Jean-François Gautier, Michel Marre, Ronan Roussel, Louis Potier. Diabetes Obes Metab 2018
2

Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms.
Karen D Corbin, Kimberly A Driscoll, Richard E Pratley, Steven R Smith, David M Maahs, Elizabeth J Mayer-Davis. Endocr Rev 2018
53

Differential association of body mass index on glycemic control in type 1 diabetes.
Eun Young Lee, Yong-Ho Lee, Sang-Man Jin, Hae Kyung Yang, Chang Hee Jung, Cheol-Young Park, Jae Hyoung Cho, Woo Je Lee, Byung-Wan Lee, Jae Hyeon Kim. Diabetes Metab Res Rev 2017
4


Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Jonathan Q Purnell, Barbara H Braffett, Bernard Zinman, Rose A Gubitosi-Klug, William Sivitz, John P Bantle, Georgia Ziegler, Patricia A Cleary, John D Brunzell. Diabetes Care 2017
39

Double-diabetes in a real-world sample of 2711 individuals: associated with insulin treatment or part of the heterogeneity of type 1 diabetes?
Fernando M A Giuffrida, Caroline Bulcão, Roberta A Cobas, Carlos Antonio Negrato, Marilia B Gomes, Sergio Atala Dib. Diabetol Metab Syndr 2016
8

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.
Kathrin Herrmann, Steven C Brunell, Yan Li, Ming Zhou, David G Maggs. Adv Ther 2016
12


Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?
D Russell-Jones, T Danne, K Hermansen, K Niswender, K Robertson, N Thalange, J R Vasselli, B Yildiz, H U Häring. Diabetes Obes Metab 2015
16

[Factors limiting glycaemic control in insulin-treated type 2 diabetes].
Viktória Ferencz, Beatrix Domján, László Gerő, Tímea Tänczer, Gy Ádám Tabák. Orv Hetil 2015
0

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Birgit Fullerton, Klaus Jeitler, Mirjam Seitz, Karl Horvath, Andrea Berghold, Andrea Siebenhofer. Cochrane Database Syst Rev 2014
173